Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruby Yun-Ju Huang

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 3, 2024
Identification of Early Events in Serrated Pathway Colorectal Tumorigenesis by Using Digital Spatial ProfilingMin-Cheng Su, Ching-Hsiang Hsu, Ko-Chen Chen, et al.
Molecular Biology of the Cell|October 21, 2020
Two high-yield complementary methods to sort cell populations by their 2D or 3D migration speedAditya Arora, Jorge Luis Galeano Niño, Myint Zu Myaing, et al.
Oncotarget|February 1, 2018
Hypoxia-inducible factor-1α promotes cell survival during ammonia stress response in ovarian cancer stem-like cellsShojiro Kitajima, Kian Leong Lee, Hiroki Hikasa, et al.
Breast Cancer Research and Treatment|February 24, 2021
Prognostic significance of phosphoglycerate dehydrogenase in breast cancerMuthukrishnan Chandrika, Pei Jou Chua, Umamaheswari Muniasamy, et al.
Molecular Oncology|December 15, 2018
The FZD7-TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinomaMing Tan, Mohammad Asad, Valerie Heong, et al.
Oncotarget|June 11, 2015
Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)Ruby Yun-Ju Huang, Kuee Theng Kuay, Tuan Zea Tan, et al.
Biomaterials|November 26, 2013
Modeling of cancer metastasis and drug resistance via biomimetic nano-cilia and microfluidicsChing-Te Kuo, Chi-Ling Chiang, Chi-Hao Chang, et al.
Scientific Reports|October 29, 2020
Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinomaAkira Yabuno, Hirokazu Matsushita, Tetsutaro Hamano, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 23, 2026
Combined targeting poly (ADP-ribose) polymerase and receptor tyrosine kinase inhibits ovarian clear cell carcinoma progression through disrupted ribosome biogenesisChiao-Yun Lin, An-Shine Chao, Angel Chao, et al.
The Cochrane Database of Systematic Reviews|February 21, 2022
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancerNatalie Yl Ngoi, Nicholas Lx Syn, Robby M Goh, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 3, 2024
Identification of Early Events in Serrated Pathway Colorectal Tumorigenesis by Using Digital Spatial ProfilingMin-Cheng Su, Ching-Hsiang Hsu, Ko-Chen Chen, et al.
Molecular Biology of the Cell|October 21, 2020
Two high-yield complementary methods to sort cell populations by their 2D or 3D migration speedAditya Arora, Jorge Luis Galeano Niño, Myint Zu Myaing, et al.
Oncotarget|February 1, 2018
Hypoxia-inducible factor-1α promotes cell survival during ammonia stress response in ovarian cancer stem-like cellsShojiro Kitajima, Kian Leong Lee, Hiroki Hikasa, et al.
Breast Cancer Research and Treatment|February 24, 2021
Prognostic significance of phosphoglycerate dehydrogenase in breast cancerMuthukrishnan Chandrika, Pei Jou Chua, Umamaheswari Muniasamy, et al.
Molecular Oncology|December 15, 2018
The FZD7-TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinomaMing Tan, Mohammad Asad, Valerie Heong, et al.
Oncotarget|June 11, 2015
Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)Ruby Yun-Ju Huang, Kuee Theng Kuay, Tuan Zea Tan, et al.
Biomaterials|November 26, 2013
Modeling of cancer metastasis and drug resistance via biomimetic nano-cilia and microfluidicsChing-Te Kuo, Chi-Ling Chiang, Chi-Hao Chang, et al.
Scientific Reports|October 29, 2020
Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinomaAkira Yabuno, Hirokazu Matsushita, Tetsutaro Hamano, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 23, 2026
Combined targeting poly (ADP-ribose) polymerase and receptor tyrosine kinase inhibits ovarian clear cell carcinoma progression through disrupted ribosome biogenesisChiao-Yun Lin, An-Shine Chao, Angel Chao, et al.
The Cochrane Database of Systematic Reviews|February 21, 2022
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancerNatalie Yl Ngoi, Nicholas Lx Syn, Robby M Goh, et al.
Pageof 9